Sono-Tek (SOTK) 21st Virtual Investor Summit Microcap Event summary
Event summary combining transcript, slides, and related documents.
21st Virtual Investor Summit Microcap Event summary
13 Jan, 2026Leadership and company background
CEO Steve Harshbarger highlighted his long tenure and the experienced management team.
The company was founded in 1975, based on the invention of the ultrasonic atomizing nozzle.
The core technology transitioned from R&D devices to large-scale system solutions over decades.
Technology and market focus
Ultrasonic nozzles enable precise, thin-film coatings for diverse applications.
Key markets include microelectronics, alternative energy, medical devices, industrial, and R&D.
Focused growth in disruptive sectors like semiconductors, solar, and medical coatings.
Financial performance and growth
FY 2024 saw 30% year-over-year revenue growth and $1.4 million net income.
Maintained profitability even during supply chain disruptions, with gross margins above 45%.
Strong cash position ($12 million), zero debt, and ownership of facilities.
Latest events from Sono-Tek
- Leadership in ultrasonic coatings, global reach, and scalable solutions drive growth.SOTK
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - 4% revenue growth to $20.5M, $1.27M net income, and strong backlog support near-term growth.SOTK
Q4 20253 Feb 2026 - Record backlog and clean energy demand drive double-digit first half growth and profitability.SOTK
Q2 202519 Jan 2026 - Record backlog and 50% gross margin drive 24% net income growth despite flat sales.SOTK
Q3 202613 Jan 2026 - Record revenue, 150% medical sales growth, and 50% backlog increase offset sector declines.SOTK
Q2 20267 Jan 2026 - Proxy covers director elections, auditor ratification, and executive pay, with focus on governance and oversight.SOTK
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor change, executive pay, and board governance.SOTK
Proxy Filing1 Dec 2025 - Net income rose 47% to $485K as gross margin hit 52% on strong clean energy demand.SOTK
Q1 202610 Jul 2025 - Net income surged on 40% sales growth, led by medical and clean energy demand.SOTK
Q1 202513 Jun 2025